Concepts (97)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Bile Acids and Salts | 7 | 2025 | 25 | 3.030 |
Why?
|
| Liver | 9 | 2026 | 497 | 2.530 |
Why?
|
| Fibroblast Growth Factors | 4 | 2025 | 26 | 2.410 |
Why?
|
| Cullin Proteins | 3 | 2025 | 12 | 1.840 |
Why?
|
| Cholestasis | 2 | 2025 | 13 | 1.670 |
Why?
|
| Glycine | 2 | 2025 | 34 | 1.660 |
Why?
|
| Fatty Liver | 3 | 2025 | 79 | 1.650 |
Why?
|
| Hyperglycemia | 2 | 2024 | 79 | 1.450 |
Why?
|
| Thiazepines | 2 | 2021 | 4 | 1.360 |
Why?
|
| Methylamines | 2 | 2021 | 6 | 1.360 |
Why?
|
| Cholesterol | 2 | 2021 | 204 | 1.180 |
Why?
|
| Mice | 12 | 2026 | 4870 | 1.040 |
Why?
|
| NEDD8 Protein | 2 | 2025 | 7 | 0.950 |
Why?
|
| Insulin Resistance | 2 | 2025 | 176 | 0.940 |
Why?
|
| Cholic Acids | 1 | 2025 | 3 | 0.930 |
Why?
|
| Anti-Obesity Agents | 1 | 2025 | 5 | 0.920 |
Why?
|
| Organic Anion Transporters, Sodium-Dependent | 2 | 2021 | 3 | 0.840 |
Why?
|
| Symporters | 2 | 2021 | 9 | 0.840 |
Why?
|
| Animals | 13 | 2026 | 10806 | 0.830 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 2 | 2022 | 15 | 0.830 |
Why?
|
| Adipose Tissue | 1 | 2025 | 197 | 0.810 |
Why?
|
| Chemical and Drug Induced Liver Injury | 1 | 2024 | 35 | 0.800 |
Why?
|
| Drug-Related Side Effects and Adverse Reactions | 1 | 2024 | 67 | 0.770 |
Why?
|
| Amino Acids, Sulfur | 1 | 2022 | 2 | 0.750 |
Why?
|
| Mice, Inbred C57BL | 6 | 2026 | 1684 | 0.710 |
Why?
|
| Cyclopentanes | 1 | 2022 | 17 | 0.710 |
Why?
|
| Liver Diseases, Alcoholic | 1 | 2021 | 5 | 0.680 |
Why?
|
| Mice, Knockout | 4 | 2025 | 881 | 0.670 |
Why?
|
| Receptor, Insulin | 1 | 2022 | 93 | 0.670 |
Why?
|
| Pyrimidines | 1 | 2022 | 129 | 0.660 |
Why?
|
| Insulin | 1 | 2022 | 325 | 0.620 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 1 | 2021 | 77 | 0.610 |
Why?
|
| Lipid Metabolism | 1 | 2021 | 159 | 0.600 |
Why?
|
| Obesity | 1 | 2025 | 705 | 0.600 |
Why?
|
| Ubiquitin-Protein Ligases | 3 | 2025 | 72 | 0.600 |
Why?
|
| Hepatocytes | 2 | 2026 | 97 | 0.420 |
Why?
|
| Male | 8 | 2026 | 14126 | 0.400 |
Why?
|
| Coenzyme A | 2 | 2024 | 13 | 0.400 |
Why?
|
| Cysteine | 2 | 2024 | 68 | 0.380 |
Why?
|
| Glutathione | 2 | 2024 | 77 | 0.380 |
Why?
|
| Lipids | 2 | 2024 | 220 | 0.350 |
Why?
|
| Antioxidants | 2 | 2024 | 228 | 0.340 |
Why?
|
| Cell Line | 2 | 2022 | 705 | 0.290 |
Why?
|
| Mice, Obese | 1 | 2025 | 22 | 0.230 |
Why?
|
| Adipogenesis | 1 | 2025 | 27 | 0.230 |
Why?
|
| Drug Synergism | 1 | 2025 | 106 | 0.230 |
Why?
|
| Liver Cirrhosis | 2 | 2023 | 78 | 0.230 |
Why?
|
| Disease Models, Animal | 2 | 2021 | 1524 | 0.220 |
Why?
|
| Adipocytes | 1 | 2025 | 60 | 0.220 |
Why?
|
| Protein Kinases | 1 | 2026 | 164 | 0.220 |
Why?
|
| Cellular Senescence | 1 | 2026 | 149 | 0.220 |
Why?
|
| Kelch-Like ECH-Associated Protein 1 | 1 | 2024 | 16 | 0.210 |
Why?
|
| Cysteine Dioxygenase | 1 | 2024 | 1 | 0.210 |
Why?
|
| Taurine | 1 | 2024 | 9 | 0.210 |
Why?
|
| Acetaminophen | 1 | 2024 | 12 | 0.210 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2025 | 140 | 0.200 |
Why?
|
| NAD | 1 | 2024 | 104 | 0.200 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2023 | 24 | 0.190 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2022 | 40 | 0.190 |
Why?
|
| Methionine Adenosyltransferase | 1 | 2022 | 3 | 0.190 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2024 | 130 | 0.190 |
Why?
|
| Cystine | 1 | 2022 | 7 | 0.190 |
Why?
|
| Methionine | 1 | 2022 | 38 | 0.190 |
Why?
|
| Dietary Proteins | 1 | 2022 | 35 | 0.190 |
Why?
|
| Mitochondria | 1 | 2026 | 419 | 0.180 |
Why?
|
| Fibrosis | 1 | 2023 | 145 | 0.180 |
Why?
|
| Ubiquitins | 1 | 2022 | 7 | 0.180 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2022 | 64 | 0.180 |
Why?
|
| Ubiquitination | 1 | 2022 | 33 | 0.180 |
Why?
|
| Humans | 4 | 2025 | 29211 | 0.180 |
Why?
|
| Homeostasis | 1 | 2022 | 122 | 0.170 |
Why?
|
| Angiogenic Proteins | 1 | 2021 | 4 | 0.170 |
Why?
|
| Transaminases | 1 | 2021 | 10 | 0.170 |
Why?
|
| Oxidation-Reduction | 1 | 2022 | 381 | 0.170 |
Why?
|
| Dependovirus | 1 | 2021 | 17 | 0.170 |
Why?
|
| Fructose | 1 | 2021 | 23 | 0.170 |
Why?
|
| Multidrug Resistance-Associated Proteins | 1 | 2021 | 19 | 0.170 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2021 | 58 | 0.170 |
Why?
|
| Genetic Vectors | 1 | 2021 | 119 | 0.160 |
Why?
|
| Cholesterol 7-alpha-Hydroxylase | 1 | 2020 | 1 | 0.160 |
Why?
|
| Hep G2 Cells | 1 | 2020 | 31 | 0.160 |
Why?
|
| Hypercholesterolemia | 1 | 2020 | 21 | 0.160 |
Why?
|
| Ileum | 1 | 2020 | 26 | 0.160 |
Why?
|
| Combined Modality Therapy | 1 | 2021 | 303 | 0.160 |
Why?
|
| Genetic Therapy | 1 | 2021 | 125 | 0.160 |
Why?
|
| Diet, Western | 1 | 2020 | 45 | 0.150 |
Why?
|
| Oxidative Stress | 1 | 2024 | 692 | 0.150 |
Why?
|
| Female | 3 | 2025 | 15825 | 0.150 |
Why?
|
| Gene Expression Profiling | 1 | 2021 | 479 | 0.140 |
Why?
|
| Aging | 1 | 2026 | 1041 | 0.140 |
Why?
|
| Gene Expression Regulation | 1 | 2021 | 646 | 0.130 |
Why?
|
| Signal Transduction | 1 | 2022 | 1502 | 0.110 |
Why?
|
| Treatment Outcome | 1 | 2021 | 2442 | 0.110 |
Why?
|
| Hepatic Stellate Cells | 1 | 2022 | 23 | 0.050 |
Why?
|
| Estradiol | 1 | 2022 | 176 | 0.040 |
Why?
|
| Collagen | 1 | 2022 | 157 | 0.040 |
Why?
|
| Longevity | 1 | 2022 | 141 | 0.040 |
Why?
|